19-35527222-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001166034.2(SBSN):c.1060G>A(p.Val354Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,383,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1060G>A | p.Val354Ile | missense_variant | 1/4 | ENST00000452271.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1060G>A | p.Val354Ile | missense_variant | 1/4 | 1 | NM_001166034.2 | P2 | |
SBSN | ENST00000518157.1 | c.376-345G>A | intron_variant | 1 | A2 | ||||
SBSN | ENST00000588674.5 | c.315+685G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 3AN: 151376Hom.: 0 Cov.: 34 FAILED QC
GnomAD3 exomes AF: 0.0000845 AC: 12AN: 142050Hom.: 0 AF XY: 0.0000922 AC XY: 7AN XY: 75914
GnomAD4 exome AF: 0.0000267 AC: 37AN: 1383708Hom.: 0 Cov.: 68 AF XY: 0.0000352 AC XY: 24AN XY: 682742
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000198 AC: 3AN: 151500Hom.: 0 Cov.: 34 AF XY: 0.0000270 AC XY: 2AN XY: 74052
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.1060G>A (p.V354I) alteration is located in exon 1 (coding exon 1) of the SBSN gene. This alteration results from a G to A substitution at nucleotide position 1060, causing the valine (V) at amino acid position 354 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at